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Risk factors for hospital morbidity and mortality after the Norwood
procedure: A report from the Pediatric Heart Network Single
Ventricle Reconstruction trial
Sarah Tabbutt, MD, PhD,a Nancy Ghanayem, MD,b Chitra Ravishankar, MD,a Lynn A. Sleeper, ScD,c
David S. Cooper, MD, MPH,d Deborah U. Frank, MD, PhD,e Minmin Lu, MS,c Christian Pizarro, MD,f
Peter Frommelt, MD,b Caren S. Goldberg, MD,g Eric M. Graham, MD,h Catherine Dent Krawczeski, MD,i
Wyman W. Lai, MD,j Alan Lewis, MD,k Joel A. Kirsh, MD,l Lynn Mahony, MD,m Richard G. Ohye, MD,g
Janet Simsic, MD,n Andrew J. Lodge, MD,o Ellen Spurrier, MD,f Mario Stylianou, PhD,p and
Peter Laussen, MD,q for the Pediatric Heart Network Investigators
Objectives: We sought to identify risk factors for mortality and morbidity during the Norwood hospitalization in
newborn infants with hypoplastic left heart syndrome and other single right ventricle anomalies enrolled in the
Single Ventricle Reconstruction trial.

CHD

Methods: Potential predictors for outcome included patient- and procedure-related variables and center volume and
surgeon volume. Outcome variables occurring during the Norwood procedure and before hospital discharge or stage
II procedure included mortality, end-organ complications, length of ventilation, and hospital length of stay. Univariate
and multivariable Cox regression analyses were performed with bootstrapping to estimate reliability for mortality.
Results: Analysis included 549 subjects prospectively enrolled from 15 centers; 30-day and hospital mortality
were 11.5% (63/549) and 16.0% (88/549), respectively. Independent risk factors for both 30-day and hospital
mortality included lower birth weight, genetic abnormality, extracorporeal membrane oxygenation (ECMO) and
open sternum on the day of the Norwood procedure. In addition, longer duration of deep hypothermic circulatory
arrest was a risk factor for 30-day mortality. Shunt type at the end of the Norwood procedure was not a significant
risk factor for 30-day or hospital mortality. Independent risk factors for postoperative renal failure (n ¼ 46), sepsis (n ¼ 93), increased length of ventilation, and hospital length of stay among survivors included genetic abnormality, lower center/surgeon volume, open sternum, and post-Norwood operations.
Conclusions: Innate patient factors, ECMO, open sternum, and lower center/surgeon volume are important risk
factors for postoperative mortality and/or morbidity during the Norwood hospitalization. (J Thorac Cardiovasc
Surg 2012;144:882-95)
Risk factors for hospital morbidity and mortality after the
Norwood procedure for patients with hypoplastic left heart
syndrome (HLHS) have been reported from single centers
and multicenter databases. Many centers report low birth
weight, genetic abnormalities, restrictive atrial septum, duration of cardiopulmonary bypass (CPB), and extracorporeal membrane oxygenation (ECMO) as risk factors for

mortality.1-14 Multicenter reports have shown higher
mortality at smaller volume centers.2,15,16
The Pediatric Heart Network Single Ventricle Reconstruction (SVR) trial provides a unique opportunity to analyze
prospectively collected preoperative, operative, and postoperative data in the largest cohort of newborn infants with
HLHS and other single right ventricle anomalies to date.
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Primary results of the SVR trial reported differences in outcome between subjects undergoing the Norwood procedure
with a right ventricular–pulmonary artery shunt (RVPAS)
versus a modified Blalock-Taussig shunt (MBTS).17 The initial report focused solely on the comparative outcomes relative to shunt type. The primary aim of this prespecified
secondary analysis was to examine the associations of
patient-related risk factors and perioperative management
variables on morbidity and mortality during the Norwood
hospitalization. To facilitate comparisons with previous reports of surgical morality for the Norwood procedure, we analyzed both 30-day and hospital mortality. Our secondary
aim was to explore associations with shunt type on longerterm transplant-free survival in subjects requiring cardiopulmonary resuscitation (CPR) and/or ECMO.
METHODS
Study Design
Details of the SVR trial design have been previously published.17,18 In
brief, inclusion criteria consisted of a diagnosis of HLHS or other single
right ventricle anomaly and a planned Norwood procedure. Patients were
excluded if the preoperative cardiac anatomy rendered either the MBTS
or RVPAS technically impossible or if they had any major congenital or
acquired extracardiac abnormality that could independently decrease the
likelihood of transplant-free survival at 1 year of age. Subjects were randomly assigned to receive either the MBTS or the RVPAS. The institutional
review board at each center approved the protocol. Written informed consent was obtained from a parent/guardian before randomization. Other than
the type of shunt placed, the remainder of the perioperative care was per
institutional standard. For the purposes of this analysis, subjects were categorized by the shunt in place at the end of the Norwood procedure.

Data Collection and Definitions
Data were prospectively collected. The 16 outcome variables are defined
in Appendix Table 1. Other than 30-day mortality, outcomes were recorded
if they occurred before hospital discharge or before stage II procedure for
subjects not discharged. ECMO initiated after the Norwood procedure
was considered an outcome variable. The 42 potential risk factors are defined in Appendix Table 2. Subjects underwent genetic evaluations when
indicated by clinical suspicion of a genetic abnormality. In addition, a research option for a genetic evaluation was offered. Preoperative shock

Statistical Methods
Summary statistics include mean  standard deviation, median, and
range. We analyzed 2 mortality outcomes: (1) time to death up to discharge
from the Norwood hospitalization, using Kaplan-Meier estimation and Cox
proportional hazards regression, with censoring at dates of cardiac transplant and at time of stage II procedure (for those not discharged) and (2) a dichotomous 30-day post-Norwood procedure mortality indicator, using
logistic regression. We analyzed 4 continuous outcomes using linear
regression: post-Norwood right ventricular fractional area change, logtransformed time to initial extubation, log-transformed total days ventilated, and log-transformed hospital length of stay. Subjects who died or
underwent cardiac transplant during the hospitalization were excluded
from analysis of the extubation, ventilation, and length of stay outcomes.
We analyzed 10 dichotomous morbidity outcomes using logistic regression;
for 3 of these (necrotizing enterocolitis, liver failure, mediastinitis), only
univariate analyses were conducted owing to the low event rate. For construction of multivariable models, variables with a P value  .2 in univariate
analysis were used as candidate predictors in regression modeling. The R2
and maximum rescaled R2 values are reported for linear and logistic regression models, respectively. In addition, generalized additive modeling was
used to identify nonlinear associations between outcomes and continuous
candidate predictors. Variables with a nonlinearity P value<.05 were considered in the multivariable selection procedure. Bootstrap resampling was
used to estimate the reliability of each factor selected by stepwise regression
for the multivariable mortality model.19,20 We retained a term in the model
if it had reliability greater than 50% and a P value of less than .05.
We used analysis of variance and the Kruskal-Wallis test for comparison of
the distributions of baseline characteristics across the 4 ECMO/CPR groups.
To account for potential survival bias in this secondary analysis of CPR with
or without ECMO subjects, we used Cox proportional hazards regression with
a time-dependent group indicator to model time to death or transplant, using
all available follow-up data. A test of interaction between subject group and
shunt type was used to assess differential treatment effect by group.

RESULTS
Between May 2005 and July 2008 there were 549 evaluable SVR subjects: 268 with an MBTS and 281 with an
RVPAS.
Mortality
Mortality during the Norwood hospitalization was 16%
(88/549). Deaths occurred at a median of 16 days, (range,
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Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
CPR ¼ cardiopulmonary resuscitation
DHCA ¼ deep hypothermic circulatory arrest
ECMO ¼ extracorporeal membrane oxygenation
E-CPR ¼ ECMO required to restore circulation
during CPR
HLHS ¼ hypoplastic left heart syndrome
MBTS ¼ modified Blalock-Taussig shunt
RCP ¼ regional cerebral perfusion
RVPAS ¼ right ventricular–pulmonary artery shunt
SVR ¼ Single Ventricle Reconstruction

was defined as a composite of hepatic failure (Appendix Table 1), renal failure (Appendix Table 1), lactate greater than 10 mmol/L, or intubation for
shock. Perfusion strategies included deep hypothermic circulatory arrest
(DHCA) alone or regional cerebral perfusion (RCP) with or without
DHCA. Open sternum included all subjects with an open sternum on the
day of the Norwood procedure. These subjects were categorized as those
at a ‘‘routine’’ center where sternums of all patients were left open at the
end of the Norwood procedure or those at an ‘‘elective’’ center where the
surgeon selectively decided to leave the patient’s sternum open. ECMO
for failure to separate from CPB was examined as a potential risk factor.
The day of Norwood procedure was defined as day 1.
The longer-term outcome of patients requiring CPR (defined as receiving chest compressions) and/or ECMO was examined in further detail.
Subjects were characterized as follows: CPR alone (CPR), ECMO alone
(ECMO), ECMO required to restore circulation during CPR (E-CPR),
and neither CPR nor ECMO (‘‘none’’). For the subanalysis of these 4
groups, only CPR, ECMO, or E-CPR occurring within 30 days of Norwood
procedure were included. Subjects requiring ECMO for failure to separate
from CPB were included in the ECMO group.
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age at surgery. Significant risk factors by multivariable analysis, for 30-day and hospital mortality, are shown in Table 1.
Shunt type was not a significant risk factor for mortality.
ECMO and open sternum on the day of the Norwood procedure were the strongest risk factors for mortality. ECMO
was initiated during the Norwood procedure in 8% of subjects with open sternum and 1% of subjects with closed
sternum (P ¼ .002). Open sternum remained a significant
risk factor for mortality with ECMO included in the multivariable model. Sternums were routinely left open in all patients at 7 centers (median hospital mortality, 18%; range,
2%-39%) and sternums were electively left open at 8 centers (median hospital mortality, 13%; range, 0%-30%).
The 7 routine open sternum centers represented 59%
(244/415) of the subjects with open sternum. The mortality
risk of open sternum did not differ significantly between
routine and elective centers. For the open sternum cohort,
reliability by bootstrapping methodology for hospital mortality was high at 90%. Although subjects with the anatomic subtype of mitral stenosis with aortic atresia were
more likely to require ECMO during the Norwood procedure (13% vs 4%; P < .001), mitral stenosis with aortic
atresia was not an independent risk factor for 30-day
(P ¼ .23) or hospital (hazard ratio, 1.48; 95% confidence
interval, 0.92-2.36; P ¼ .1) mortality.

FIGURE 1. Kaplan-Meier estimates and pointwise 95% confidence
bands for hospital survival after the Norwood procedure (N ¼ 549). Patients were censored when they were transplanted (n ¼ 9) or discharged
(n ¼ 430).

1-149 days). The 30-day mortality was 12% (63/549).
Figure 1 shows the Kaplan-Meier survival curve for all subjects during the Norwood hospitalization. Included among
the survivors were 9 subjects who underwent cardiac transplantation before discharge; median time to transplant was
51 days after the Norwood procedure (range, 9-270 days).
There were 22 subjects who remained in the hospital until
the stage II procedure; median time to stage II procedure
was 116 days (range, 49-271 days).
Significant risk factors by univariate analysis for 30-day
mortality included the following: lower birth weight, lower
gestational age, genetic abnormality, duration of DHCA,
duration of total support time, ECMO for failure to separate
from CPB, open sternum at the Norwood procedure, and
surgeon Norwood volume. Additional risk factors by univariate analysis for Norwood hospital mortality included
preoperative intervention on the atrial septum and younger

Morbidity
Results of multivariable analyses for the morbidity outcomes are shown in Table 2. Shunt type was only an independent risk factor for CPR (odds ratio, 2.02; P ¼ .005)
and decreased ventricular function as measured by postoperative echocardiographic fractional area change (odds ratio, 3.59; P < .001) with the MBTS compared with the
RVPAS. Genetic abnormality, center volume, surgeon volume, open sternum, and post-Norwood operations were
the most common independent risk factors for postNorwood morbidities.

TABLE 1. Independent risk factors for 30-day and hospital mortality after the Norwood procedure
Thirty-day mortality

Hospital mortality

Candidate predictor

Odds ratio

95% CI

P

Hazard ratio

95% CI

P

Reliability

Birth weight, kg
Genetic abnormality
Yes
No
Unknown
DHCA duration, min
ECMO at Norwood procedure
Open sternum
Yes, routine site
Yes, elective site
No, elective site

0.52

(0.29, 0.94)

.03
<.001

0.62

(0.41, 0.93)

.02
<.001

63%
81%

2.93
Ref
13.6
1.10
4.38

(0.78, 10.9)

2.89
Ref
6.42

(1.21, 6.9)
(3.67, 11.2)

3.41

(1.94, 5.98)

<.001
.002

69%
90%

5.87
4.25
Ref

(2.22,15.6)
(1.65, 10.6)

18.1
5.81
Ref

(6.23, 29.5)
(1.03, 1.19)
(1.76, 10.9)
(5.17, 63.4)
(1.75, 19.3)

.01
.002
<.001

CI, Confidence interval; DHCA, deep hypothermic circulatory arrest; ECMO, extracorporeal membrane oxygenation; Ref, reference group.
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TABLE 2. Multivariable models for morbidity outcomes after the Norwood procedure

Catheter intervention (R ¼ 7%)
Preoperative intubation for apnea/transport
Left atrial decompression
Regional cerebral perfusion
Central nervous system injury (R2 ¼ 4%)
Genetic abnormality
Yes
No
Unknown
Renal failure (R2 ¼ 26%)
Anomalous pulmonary venous return
Preoperative intubation for apnea/transport
Heart block
Open sternum
Yes, routine site
Yes, elective site
No, elective site
Surgeon Norwood volume
5/y
6 to 10/y
11 to 15/y
>15/y
Center volume
15/y
16 to 20/y
21 to 15/y
>30/y
Sepsis (R2 ¼ 16%)
Gestational age, wk
AS/MS/VSD
Duration of DHCA, min
Open sternum duration, d
Center volume
15/y
16 to 20/y
21 to 30/y
>30/y
ECMO after Norwood procedure (R2 ¼ 40%)
Birth weight <2.5 kg
Yes
No
Age at Norwood procedure, d
Operations after Norwood procedure
CPR (R2 ¼ 25%)
Birth weight, kg
Genetic abnormality
Yes
No
Unknown
Shunt
MBTS
RVPAS
Operations after Norwood procedure
2

No. of subjects
with event

Time to event, days;
median (range)

27

27 (2-129)

38

Odds
ratio

95% CI

P

0.23
4.02
2.11

(0.05, 0.97)
(1.19, 13.6)
(1.04, 4.29)

.05
.03
.04

2.84
Ref
2.68

(1.29, 6.28)

10.2
3.46
18.8

(2.43, 42.4)
(1.66, 7.21)
(5.05, 70)

7.61
6.72
Ref

(1.86, 31.2)
(1.62, 27.9)

0.31
0.90
0.20
Ref

(0.09, 1.09)
(0.28, 2.91)
(0.06, 0.61)

1.55
0.44
0.32
Ref

(0.53, 4.58)
(0.14, 1.45)
(0.11, 0.91)

0.79
3.81
1.07
1.08

(0.68, 0.92)
(1.05, 13.9)
(1.004, 1.13)
(1.05, 1.12)

2.28
0.94
0.64
Ref

(1.17, 4.47)
(0.40, 2.19)
(0.33, 1.26)

2.38
Ref
0.87
2.23

(1.04, 5.44)
(0.78, 0.98)
(1.84, 2.69)

.02
<.01

0.54

(0.34, 0.85)

.008
<.001

0.32
0.28
Ref

(0.17, 0.62)
(0.16, 0.49)

2.02
Ref
1.51

(1.23, 3.32)

5 (1-157)
.01

46

(1.27, 5.64)

3 (1-77)
.002
<.001
<.001
.02

.006

.02

93

56

19 (1-133)
.002
.04
.04
<.001
.003

2 (1-149)
.04

97

5 (1-149)

.005

(1.32, 1.73)

<.001
(Continued)
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TABLE 2. Continued
Outcome

No. of subjects
with event

Time to event, days;
median (range)

112

NA

TR (2.5 mm) (R ¼ 11%)
TR (2.5 mm) preoperative
Open sternum
Yes, routine site
Yes, elective site
No, elective site
Heart block
2

CHD

Outcome

N

Median (range)

Fractional area change, % (R2 ¼ 13%)
Fractional area change preoperatively, %
Shunt
MBTS
RVPAS
ECMO at Norwood procedure
Yes
No
Log time to first extubation, d (R2 ¼ 59%)
Gestational age, wk
Left atrial decompression
Yes
No
TR (2.5 mm) preoperatively
Yes
No
Duration of regional cerebral perfusion, min
ECMO at Norwood procedure
Yes
No
Open sternum
Yes, routine site
Yes, elective site
No, elective site
Duration of open sternum, d
Operations after Norwood procedure
Center volume
15/y
16 to 20/y
21 to 30/y
>30/y
Surgeon Norwood volume
5/y
6 to 10/y
11 to 15/y
>16/y
Log, length of ventilation, d (R2 ¼ 59%)
Gestational age, wk
Genetic abnormality
Yes
No
Unknown
Preoperative intubation for any reason
Yes
No

452

36 (12-63)

Odds
ratio

95% CI

2.92

(1.55, 5.49)

2.11
3.21
Ref
5.29

(1.12, 3.96)
(1.66, 6.23)

Slope or mean diff

(1.41, 19.85)
Adjusted mean

P
.001
.003

.01
P
<.001
<.001

0.23
3.59

32.2
35.8

5.34

31.4
36.7

.007

447

5.1 (0.6-109)
0.06

<.001
.01

0.46
Ref

5.50
5.04

0.15
Ref
0.0002

5.34
5.20

0.50
Ref

5.52
5.02

0.55
0.45
Ref
0.02
0.15

5.49
5.38
4.93

0.06
0.31
0.21
Ref

5.09
5.46
5.36
5.15

0.54
0.54
0.40
Ref

5.44
5.44
5.30
4.90

.03

.04
.001

<.001

.03
<.001
<.001

<.001

447

7 (1-270)
0.06

<.001
<.001

0.44
Ref
0.16

2.82
2.55
2.38

0.19
Ref

2.68
2.49

.001

(Continued)
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TABLE 2. Continued
N

Left atrial decompression
Yes
No
Preoperative shock
Yes
No
TR (2.5 mm) preoperatively
Yes
No
Age at Norwood procedure, d
Open sternum
Yes, routine site
Yes, elective site
No, elective site
Operations after Norwood procedure
Center volume
15/y
16 to 20/y
21 to 30/y
>30/y
Surgeon Norwood volume
5/y
6 to 10/y
11 to 15/y
>16/y
Log, hospital length of stay, d (R2 ¼ 49%)
Birth weight, kg
Genetic abnormality
Yes
No
Unknown
Preoperative intubation for shock
Yes
No
TR (2.5 mm) preoperative
Yes
No
Duration of DHCA, min
45 min
>45 min
Operations after Norwood procedure
Center volume
15/y
16 to 20/y
21 to 30/y
>30/y

Median (range)

Slope or mean diff

Adjusted mean

0.49
Ref

2.83
2.34

0.27
Ref

2.72
2.45

0.24
Ref
0.02

2.70
2.47

0.25
0.20
Ref
0.34

2.69
2.63
2.43

0.004
0.26
0.12
Ref

2.49
2.75
2.61
2.49

0.33
0.27
0.21
Ref

2.71
2.65
2.59
2.38

P
.02

.02

.004

.02
.006

<.001
.005

CHD

Outcome

.008

452

24 (6-270)
0.01

.03
.007

0.33
Ref
0.06

3.78
3.44
3.5

0.15
Ref

3.66
3.5

0.15
Ref

3.65
3.5

0.017
Ref
0.27

3.49
3.66

0.16
0.34
0.03
Ref

3.62
3.8
3.43
3.46

.009

.04

.003

<.001
<.001

CI, Confidence interval; Ref, reference group; AS/MS/VSD, aortic stenosis, mitral stenosis, ventricular septal defect; DHCA, deep hypothermic circulatory arrest; ECMO,
extracorporeal membrane oxygenation; CPR, cardiopulmonary resuscitation; MBTS, modified Blalock-Taussig; RVPAS, right ventricle–pulmonary artery shunt; TR, tricuspid
regurgitation; NA, not available; Diff, difference.

Less frequent morbidities were explored by univariate
analyses. Hepatic failure occurred in 16 subjects at a median
of 22 days (range, 2-159 days) after the Norwood procedure. Fifty percent (8/16) of the subjects with hepatic failure
died before discharge. Significant risk factors for hepatic
failure included lower birth weight (P ¼ .02), aortic atresia

(P ¼ .03), MBTS (P ¼ .04), longer support time (P ¼ .05),
and heart block on the day of the Norwood procedure
(P ¼ .02). Mediastinitis occurred in 15 subjects at a median
of 8 days (range, 3-35 days) after the Norwood procedure.
Significant risk factors for mediastinitis included preoperative intubation for apnea or transport (P ¼ .04), RVPAS
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TABLE 3. Baseline characteristics of subjects requiring ECMO, CPR, E-CPR, or neither interventions (none) within the first 30 days after
Norwood procedure
Variable
Birth weight, kg
Birth weight <2.5 kg
Gestational age, wk
Age at Norwood procedure, d
Ascending aorta, mm*
TR 2.5 mm, preoperativey
Fractional area change,
preoperative, %z
Incidence of event within shunt type
MBTS (268)
RVPAS (281)
P

CPR (37)

ECMO (49)

E-CPR (36)

None (427)

P

2.89  .7
10 (27%)
37.6  2.1
6.2  3.6
3.1  1.4
3 (9%)
49  11

3.12  .6
9 (18%)
38.2  1.7
5.0  3.0
2.8  1.5
3 (6%)
46  8

2.95  .6
11 (31%)
37.9  1.5
4.8  2.8
2.9  1.8
4 (13%)
47  8

3.13  .5
46 (11%)
38.2  1.6
5.9  4.3
3.2  1.8
25 (6%)
46  9

.09
<.001
.20
.11
.27
.47
.34

23 (9%)
14 (5%)
.13

27 (10%)
22 (8%)
.37

22 (8%)
14 (5%)
.17

196 (73%)
231 (82%)

ECMO, Extracorporeal membrane oxygenation; CPR, cardiopulmonary resuscitation; E-CPR, ECMO required to restore circulation during CPR; TR, tricuspid regurgitation;
MBTS, modified Blalock Taussig shunt; RVPAS, right ventricular to pulmonary artery shunt. *Ascending aorta size by surgeon observation. ySample sizes for TR are CPR,
31; ECMO, 48; E-CPR, 35; None, 392. zSample sizes for fractional area change are CPR, 30; ECMO, 45; E-CPR, 34; None, 394.

CHD

(P ¼ .04), and heart block on the day of the Norwood procedure (P ¼ .02). Open sternum was not a risk factor for mediastinitis. Necrotizing enterocolitis occurred in 14 subjects
at a median of 22.5 days (range, 2-66 days) after the
Norwood procedure. No significant risk factors were
identified.
ECMO and CPR
Of the 549 evaluable subjects, 22% (122/549) received
CPR (n ¼ 37), ECMO (n ¼ 49), or E-CPR (n ¼ 36) within
the first 30 days after the Norwood procedure and 78%
(427/549) did not require these interventions (‘‘none’’). Important baseline characteristics among the 4 groups are
shown in Table 3. Within the ECMO, CPR, and E-CPR

groups, there was no difference in the number of subjects according to shunt type. After the Norwood procedure, the
mean time to initiation of CPR was 3.1  1.4 days, ECMO
was 1.1  1.7 days, and E-CPR was 4.7  5.9 days. Within
the ECMO subjects, 71% (35/49) required ECMO for failure
to separate from CPB. Low birth weight was more common
in the CPR and E-CPR groups (P<.001).
Longer-term survival for these subjects was examined
with a mean follow-up of 2.7  0.9 years. Subjects receiving CPR, ECMO, or E-CPR had a lower transplant-free survival (P < .0001; Figure 2). The 2-year transplant-free
survival was 35% for CPR, 26% for ECMO, 30% for
E-CPR, and 75% for the ‘‘none’’ group. The impact of
shunt type on transplant-free survival within the 4 groups
TABLE 4. Association of shunt type with transplant-free survival
within the 4 groups: CPR, ECMO, E-CPR and neither intervention
(none)

FIGURE 2. Kaplan-Meier estimates for transplant-free survival after the
Norwood procedure using all available follow-up (mean, 2.7  0.9 years
for survivors). Group classification is according to extracorporeal membrane oxygenation (ECMO), cardiopulmonary resuscitation (CPR),
ECMO required to restore circulation during CPR (E-CPR), and none of
these interventions (none) within the first 30 days after the Norwood procedure.
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Without adjustment
MBTS vs RVPAS
CPR
ECMO
E-CPR
None
Adjustment for birth weight
and surgeon
MBTS vs RVPAS
CPR
ECMO
E-CPR
None

Hazard
ratio

95% CI

P

Interaction
P*

1.28
0.82
0.62
1.42

(0.89, 1.84)
(0.43, 1.58)
(0.28, 1.36)
(0.98, 2.06)

.94
.55
.23
.07

.48
.15
.06

1.3
0.67
0.48
1.54

(0.54, 3.16)
(0.33, 1.36)
(0.21, 1.11)
(1.04, 2.28)

.56
.26
.09
.03

.74
.05
.01

ECMO, Extracorporeal membrane oxygenation; CPR, cardiopulmonary resuscitation; E-CPR, ECMO required to restore circulation during CPR; CI, confidence interval; MBTS, modified Blalock-Taussig shunt; RVPAS, right ventricle–pulmonary
artery shunt. *P value from test of interaction of shunt type and therapy group versus
none.
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is shown in Table 4. Subjects who did not require CPR or
ECMO had better survival with an RVPAS. After adjustment for surgeon and birth weight, subjects with an
MBTS had a better outcome after E-CPR or ECMO relative
to subjects with an RVPAS compared with those subjects in
the ‘‘none’’ group. This differential effect of shunt type was
not observed for the CPR group in comparison with the
‘‘none’’ group.
DISCUSSION
The primary outcome of the SVR trial demonstrated
a transplant-free survival benefit for subjects receiving an
RVPAS, which was statistically significant at 12 months
of age but no longer significant at longer follow-up (32 
11 months).17 This prespecified secondary analysis reports
the most extensive evaluation of risk factors for morbidity
and mortality during the Norwood hospitalization in a multicenter cohort of newborn infants with HLHS and other single right ventricular anomalies to date. Multivariable
analysis showed that only birth weight, genetic abnormality,
ECMO, and open sternum at the Norwood procedure were
independent risk factors for 30-day and hospital mortality,
and the duration of DHCA was an independent risk factor
for 30-day mortality.
Early outcomes for patients with HLHS have improved
substantially over the past 3 decades. Reports of early postoperative mortality are predominantly from centers achieving excellent outcomes with reported surgical survivals of
81% to 93%.3,4,7-13 Results from multiple centers have
been limited to database extraction with lower survivals
of 72% to 78%.2,15,16 Reported risk factors for early
mortality after the Norwood procedure differ among
centers and include patient-related factors such as
prematurity,10 lower birth weight,2-4,7 and presence of
genetic or noncardiac abnormalities3,10; anatomic factors
such as mitral stenosis/aortic atresia,14 smaller ascending
aorta,2 restrictive atrial septum, or significant tricuspid regurgitation4,7; preoperative factors such as shock7 and
ECMO10; operative factors such as older age at surgery,2
shunt type,11 longer DHCA,2 CPB, or total support
time4,14; and postoperative factors such as ECMO1,4,6,14
and low mixed venous saturation.13 An earlier surgical
era13 and lower center surgical volume2,15,16 have also
been associated with early mortality. Differences in
reported risk factors between centers may reflect variation
among centers, variation in patient populations, or studies
with small patient populations.
Of the independent risk factors that we identified for hospital mortality after the Norwood procedure, lower birth
weight, genetic abnormality, longer duration of DHCA,
and ECMO have been previously reported. We did not
find the type of shunt by non–intention-to-treat analysis to
be a significant risk factor for either 30-day or Norwood
hospital mortality. These findings are consistent with the

initial SVR trial report in which using intention-to-treat
analysis, death, or transplant occurred within 30 days of
the Norwood procedure in 10% (28/274) of subjects with
an RVPAS compared with 14% (38/275) with an
MBTS.17 We did not find aortic atresia, size of the ascending aorta, or preoperative shock significant by univariate
analysis. Prematurity, restrictive atrial septum requiring intervention, mitral stenosis/aortic atresia, moderate/severe
tricuspid regurgitation, younger age at surgery, longer total
support time, and lower center HLHS or surgeon Norwood
volume were significant or marginally significant by univariate analysis in our study; however, they were not found to
be risk factors for early mortality on multivariable analysis.
Open sternum remained significantly associated with
hospital and 30-day mortality after adjusting for other important independent risk factors including ECMO for failure to separate from CPB. Open sternum remained
a significant risk factor for mortality independent of the center’s strategy (elective vs routine sternal closure). Few conflicting reports address open sternum as a risk factor for
mortality.7,21 Examination of the Society of Thoracic
Surgeons Congenital Database (n ¼ 1283, 45 centers)
found 74% of patients undergoing Norwood procedure
for HLHS were managed with an open sternum.22 Surgical
mortality did not differ between centers with a high versus
a low proportion of patients with an open sternum. In addition to mortality, we found open sternum to be an independent risk factor for postoperative renal failure, moderate to
severe tricuspid regurgitation, longer time to first extubation, and duration of ventilation. We found the duration of
open sternum to be a risk factor for sepsis, although importantly, not for mediastinitis. The practice of elective sternal
closure is subject to selection bias; the patients chosen to
have the sternum closed at the Norwood procedure were
likely considered to be at lower risk for a poor outcome.
In addition, the practice of open sternum may serve as a surrogate for variability in center clinical practices, which
were not measured in this study. The decision to close the
sternum in this trial was influenced by multiple factors, including the center’s preference, the surgeon’s assessment,
and the use of ECMO with transthoracic cannulation.
Thus, it is not possible to infer causality between open sternum and mortality. However, the significantly lower mortality among patients who had their chest closed at the
conclusion of the Norwood procedure suggests that sternal
closure can be performed safely in selected patients.
Although many centers have reported risk factors for surgical or hospital mortality after the Norwood procedure,
analysis of risk factors for less frequent morbidities has
been challenging owing to small sample sizes. We found
a low (<3%) incidence of necrotizing enterocolitis, hepatic
failure, and mediastinitis. Central nervous system injury, renal failure, ECMO, and CPR occurred early with the median time to event less than 1 week after surgery. Hepatic
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failure, necrotizing enterocolitis, catheter intervention, and
sepsis tended to occur later in the postoperative course.
The impact of center volume on mortality after the Norwood procedure has been reported.15,16 However, this study
is the first multicenter report to include both center and
surgeon volumes in the risk analysis. Using the Kids’
Inpatient Database (2003, n ¼ 624 patients, 60 centers),
lower institutional HLHS volume was shown to be
a significant risk factor for Norwood hospital mortality.15
Confounding variables included in the analysis were limited. More recently, using the Society of Thoracic Surgeons
Congenital Heart Surgery Database (2011, n ¼ 2557, 53
centers), lower center Norwood procedure volume was associated with higher hospital mortality.16 We did not find
center HLHS or surgeon Norwood volume to be risk factors
for 30-day or hospital mortality. This may reflect the
different variables included in each analysis. In our analysis, if the operative variable of open sternum is not divided
into elective and routine centers, then center volume
remains in the model as an independent risk factor for hospital mortality. We did find volume to be a significant risk
factor for several important morbidities. Lower surgeon
Norwood volume was a risk factor for renal failure, longer
time to first extubation, and duration of ventilation; lower
center HLHS volume was a risk factor for sepsis, longer
time to first extubation, duration of ventilation, and hospital
length of stay.
Innate patient variables made up a majority of the independent risk factors we identified for morbidity and mortality with a few risk factors potentially modifiable. Perhaps
designating a regional HLHS center could increase center/
surgeon volume. Routine preoperative intubation for transport and apnea may be unnecessary and can potentially be
avoided with a lower dose of prostaglandin. Lower gestational age may be avoided by discouraging elective delivery
before 39 weeks.23
The need for CPR24 and ECMO1,4,6 is a serious
morbidity for infants with HLHS. Most commonly,
ECMO is reserved for extremely low cardiac output,
profound hypoxemia, or inability to regain spontaneous
circulation with CPR. Early survival after ECMO in
newborn infants with HLHS is reported at 17% to
54%.1,6,13,25 We found a low transplant-free survival for
subjects requiring ECMO, CPR, and E-CPR with attrition
continuing for months after Norwood procedure. Of note,
the survival of subjects requiring E-CPR did not differ
from that of subjects placed on ECMO for either failure
to separate from bypass or clinical deterioration without
CPR. Our data did not enable us to report the subset of
patients placed on ECMO for acute shunt failure, a subgroup reported to have better survival (83%-100%).1,6
Similar to previous reports, we found improved survival
after CPR alone for the RVPAS subjects.24 In contrast,
we found that in subjects requiring ECMO or E-CPR,
890
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the MBTS was associated with a more favorable
outcome.
Limitations
As study participation was limited to 15 participating
centers, performing 5 or more Norwood procedures annually, the inferences cannot be generalized to centers with
smaller case volumes. The only variable randomly assigned
was shunt type. Patients with a potentially higher risk of
mortality independent of a planned Norwood procedure
may be excluded by study criteria. Some subjects died before postoperative echocardiography, which could bias
these outcome measures. Formal genetic evaluation was
not obtained for all subjects, weakening the potential
strength of this candidate predictor. Genetic abnormality
was the only significant risk factor for central nervous system injury, which could reflect ascertainment bias inasmuch
as these subjects were more likely to undergo cranial imaging. Finally, we did not examine interactions between all
possible risk factors. There may be selected subgroups
with higher or lower risk for Norwood mortality or certain
morbidities that were not identified.
CONCLUSIONS
In a large, multicenter prospective cohort of newborn infants with HLHS and related right ventricular anomalies undergoing the Norwood procedure as subjects of the SVR
trial, we found lower birth weight, genetic abnormality,
ECMO for failure to separate from CPB, and open sternum
to be independent risk factors for 30-day and hospital mortality. Longer duration of DHCA was an independent risk
factor for 30-day mortality. Shunt type was not found to
be an independent risk factor for Norwood hospital mortality or morbidity outcomes with the exception that subjects
with an MBTS had decreased ventricular function on postoperative echocardiography and increased odds of CPR. Patients requiring CPR and/or ECMO after the Norwood
procedure have significantly lower transplant-free survival
and remain at risk for attrition remote from the initial event.
Although most risk factors were innate patient variables,
potentially modifiable risk factors might include preoperative intubation, lower gestational age, elective open sternum, and center/surgeon volume.
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APPENDIX TABLE 1. Outcome variables after the Norwood procedure
Outcome

CHD

N

n

Definition/comment

Mortality, 30 day
Hospital mortality

549
549

63
88

Necrotizing enterocolitis
Hepatic failure
Mediastinitis

549
549
549

14
16
15

Catheter intervention

549

38

Central nervous system injury

549

47

Renal failure

549

46

Sepsis
ECMO after Norwood procedure

549
549

93
56

CPR

549

97

Fractional area change
TR 2.5 mm
Log time to first extubation, d

452
471
447

112

Log length of ventilation, d

451

Log hospital length of stay, d

452

Includes 4 subjects who died after discharge
Mortality during or after the Norwood procedure until discharge or
stage II operation
Defined as pneumatosis intestinalis or free air
AST, ALT, GGT >500 units
Deep sternal wound infection demonstrating sternal instability or
requiring surgical incision and drainage
Transcatheter interventions (38 subjects) included: balloon dilation
and/or stent of shunt (14), balloon dilation and/or stent of branch
pulmonary artery (5), balloon dilation of the aorta (2), balloon
dilation of the aortic valve (1), atrial radiofrequency ablation (1),
innominate artery stent (3), device placed (1) and multiple
interventions (11)
Defined as intracranial bleed or stroke confirmed by imaging,
clinical or EEG seizure. Imaging was per clinical team
Creatinine >1.5 mg/dL, tripling of creatinine over <7 days or
dialysis
Confirmed positive blood culture
Postoperative ECMO, excluding patients placed on ECMO during
Norwood procedure
Postoperative CPR (defined as chest compressions), excluding CPR
during Norwood procedure
Predischarge ECHO
Predischarge ECHO showing TR jet 2.5 mm on one of two views
Deaths (88) and transplants (9) were excluded. Five subjects had
insufficient data. Log transformed data was used for analyses
Deaths (88) and transplants (9) were excluded. One subject had
insufficient data. Log transformed data was used for analyses
Discharge includes subjects transferred to other institutions.
Subjects who died (88) or were transplanted (9) were excluded.
Log transformed data was used for analyses.

N, Number of patients in analysis; n, number of patients with outcome; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyl transpeptidase; EEG,
electroencephalogram; ECMO, extracorporeal membrane oxygenation; CPR, cardiopulmonary resuscitation; ECHO, echocardiogram; TR, tricuspid regurgitation.
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APPENDIX TABLE 2. Candidate predictors
N

n

549
549
549
549
549
549

421

Mean ± SD

3.1  0.5
76
38  1.6
64
29

No

Yes, abnormal chromosomes only (3), genetic syndrome only (21),
genetic syndrome and abnormal chromosomes (5)
No, normal chromosomes and formal genetic evaluation found no
syndrome
Unknown, subjects without chromosomes or genetic evaluation
None
1
2
3

344

Unknown
Nonsyndromic anomalies

374

Genetic abnormality and/or nonsyndromic anomalies
Yes
No
Unknown
Preoperative
Preoperative intubation, any
Preoperative intubation for apnea/transport
Preoperative intubation for shock
Preoperative left atrial decompression

176
268
38
25
43

549
120
253
176
176
547
547
547
549

263
101
117
21

Preoperative surgical intervention

549

8

Preoperative bloodstream infection
Preoperative central nervous system injury

549
549

8
14

Preoperative shock

547

38

359
503
506

254

Preoperative echocardiogram
Left ventricular cavity present
Fractional area change preoperatively, %
TR 2.5 mm preoperatively

Definition/comment

Intubation, for any reason
Intubation for shock, respiratory failure or acidosis
Intervention on atrial septum for obstructed pulmonary venous
return
Non-cardiac surgical interventions: bowel surgery (2), chest tube
(2), other (4)
Defined as seizure, stroke or intracranial bleed confirmed by
imaging
See Appendix Table 2. Hepatic failure (6), renal failure (10),
elevated lactate (23), or intubation for shock (14)

35  8.6
471

Aortic stenosis
Anatomy
Aortic atresia
MS/AA
MS/AS/IVS
MS/AS/VSD
Anomalous pulmonary venous return
Ascending aorta diameter, observed, cm
Ascending aorta diameter, echocardiogram, cm

537

226

549
549
549
549
549
534
534

345
138
45
11
11

Operative
Age at Norwood procedure, d
Shunt

549
549

RV fractional area change
Width of the tricuspid regurgitation jet 2.5 mm in either AP or
lateral view
Flow through aortic valve

Mitral stenosis, aortic atresia. Mortality analyses only
Mitral stenosis, aortic stenosis with intact ventricular septum
Mitral stenosis, aortic stenosis with ventricular septal defect
0.32  0.17
0.36  0.18

Surgeon observed

5.8  4.1
Shunt in place at the end of the Norwood procedure. MBTS 268,
RVPAS 281
(Continued)
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APPENDIX TABLE 2. Continued
Candidate predictor

N

n

Mean ± SD

Regional cerebral perfusion
Yes
No
Duration of DHCA, min
Duration of DHCA > 10 min
Duration of regional cerebral perfusion, min

544
414
546

31.7  23.2
40.4  19.5
23.7  29.2

Duration of RCP, excluding DHCA alone, min
Total support time, min
ECMO at Norwood procedure

249
549
549

51.9  20.1
143  54.1
35

549

13

Perioperative
Heart block

544

CHD

549

244
171
129
538

Operations after Norwood procedure

549

429

Volume
Center volume
15
16 to 20
21 to 30
>30
Surgeon Norwood volume
5
6 to 10
11 to 15
>15

Perfusion strategy unknown (5)
RCP alone (36), with DHCA (211)

247
297

Open sternum
Yes, routine site
Yes, elective site
No, elective site
Duration of open sternum, d

544

549

Definition/comment

4.7  6.4

Subjects managed with no DHCA were included as 0 minutes
Duration of DHCA: DHCA alone (297) RCP with DHCA (117)
Subjects managed with DHCA (297) alone were included as
0 minutes.
Inclusive of CPB, DHCA, and RCP
ECMO during Norwood procedure for failure to separate from
bypass
Second- or third-degree heart block in ICU on day of Norwood
procedure
Open sternum on day of Norwood procedure
All sternums left open at routine site
Elective site with selective decision to leave sternum open
Elective site with selective decision to close sternum
Thirty-four subjects died with open sternum and date of death was
used. Subjects with closed sternum were included as 0. Eleven had
missing data
Subjects with additional surgical procedures (cardiac or other) after
the Norwood procedure and before discharge
Patients with single RV screened per center per year

93
109
176
171
549

Patients with single RV scheduled for Norwood procedure screened
per surgeon per year
108
113
239
89

N, Number of subjects for which the data were available; n, number of subjects with a predictor or number of subjects in each category; SD, standard deviation; RV, right ventricle
(ventricular); AP, anteroposterior; MBTS, modified Blalock-Taussig shunt; RVPAS, right ventricular–pulmonary artery shunt; RCP, regional cerebral perfusion; DHCA, deep hypothermic circulatory arrest; CPB, cardiopulmonary bypass; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit.

894

The Journal of Thoracic and Cardiovascular Surgery c October 2012

Tabbutt et al

Congenital Heart Disease

APPENDIX TABLE 3. Pediatric Heart Network Investigators

APPENDIX TABLE 3. Continued

National Heart, Lung, and Blood Institute: Gail Pearson, Victoria
Pemberton, Rae-Ellen Kavey,* Mario Stylianou, Marsha Mathis.*
Network Chair: University of Texas Southwestern Medical Center, Lynn
Mahony.
Data Coordinating Center: New England Research Institutes, Lynn
Sleeper (PI), Sharon Tennstedt (PI), Steven Colan, Lisa Virzi,* Patty
Connell,* Victoria Muratov, Lisa Wruck,* Minmin Lu, Dianne
Gallagher, Anne Devine,* Julie Schonbeck, Thomas Travison,* David F.
Teitel.
Core Clinical Site Investigators: Children’s Hospital Boston, Jane W.
Newburger (PI), Peter Laussen, Pedro del Nido, Roger Breitbart, Jami
Levine, Ellen McGrath, Carolyn Dunbar-Masterson, John E. Mayer, Jr.,
Frank Pigula, Emile A. Bacha, Francis Fynn-Thompson; Children’s
Hospital of New York, Wyman Lai (PI), Beth Printz,* Daphne Hsu,*
William Hellenbrand, Ismee Williams, Ashwin Prakash,* Seema Mital,*
Ralph Mosca,* Darlene Servedio,* Rozelle Corda, Rosalind Korsin,
Mary Nash*; Children’s Hospital of Philadelphia, Victoria L. Vetter
(PI), Sarah Tabbutt,* J. William Gaynor (Study Co-Chair), Chitra
Ravishankar, Thomas Spray, Meryl Cohen, Marisa Nolan, Stephanie
Piacentino, Sandra DiLullo,* Nicole Mirarchi; Cincinnati Children’s
Medical Center, D. Woodrow Benson (PI), Catherine Dent Krawczeski,
Lois Bogenschutz, Teresa Barnard, Michelle Hamstra, Rachel Griffiths,
Kathryn Hogan, Steven Schwartz,* David Nelson, Pirooz Eghtesady*;
North Carolina Consortium: Duke University, East Carolina University,
Wake Forest University, Page A. W. Anderson (PI)—deceased, Jennifer
Li (PI), Wesley Covitz, Kari Crawford,* Michael Hines, James Jaggers,*
Theodore Koutlas, Charlie Sang, Jr., Lori Jo Sutton, Mingfen Xu;
Medical University of South Carolina, J. Philip Saul (PI), Andrew Atz,
Girish Shirali, Scott Bradley, Eric Graham, Teresa Atz, Patricia Infinger;
Primary Children’s Medical Center and the University of Utah, Salt
Lake City, Utah, L. LuAnn Minich (PI), John A. Hawkins, Michael
Puchalski, Richard V. Williams, Peter C. Kouretas, Linda M. Lambert,
Marian E. Shearrow, Jun A. Porter*; Hospital for Sick Children, Toronto,
Brian McCrindle (PI), Joel Kirsh, Chris Caldarone, Elizabeth
Radojewski, Svetlana Khaikin, Susan McIntyre, Nancy Slater;
University of Michigan, Caren S. Goldberg (PI), Richard G. Ohye (Study
Chair), Cheryl Nowak*; Children’s Hospital of Wisconsin and Medical
College of Wisconsin, Nancy S. Ghanayem (PI), James S. Tweddell,
Kathleen A. Mussatto, Michele A. Frommelt, Peter C. Frommelt, Lisa
Young-Borkowski.
Auxiliary Sites: Children’s Hospital Los Angeles, Alan Lewis (PI),
Vaughn Starnes, Nancy Pike; The Congenital Heart Institute of Florida
(CHIF), Jeffrey P. Jacobs (PI), James A. Quintessenza, Paul J. Chai,
David S. Cooper, J. Blaine John, James C. Huhta, Tina Merola, Tracey
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